Download Andrea ARFE - Bocconi University

Via Sarfatti 25
20136 Milano
Curriculum Vitae – October 2016 Family name: Arfè Given name: Andrea Gender: Male Date of birth: 19/11/1985 Citizenship: Italian email address: [email protected] website: andreaarfe.wordpress.com Qualifications 2014: MSc degree (2 years), with honors: Biostatistics, University of Milano‐Bicocca, Milan, Italy. 2010: BSc degree (3 years), with honors: Statistics, University of Milano‐Bicocca, Milan, Italy. Awards and Scholarships 2016: Academic merit award, PhD in Statistics, Bocconi University 2015: PhD Fellowship, Bocconi University Research Interests Bayesian statistics; mathematical statistics; biostatistics and epidemiology; causal inference; functional data analysis. Publications Arfè A, Scotti L, Varas‐Lorenzo C, Nicotra F, Zambon A, Kollhorst B, Schink T, Garbe E, Herings R, Straatman H, Schade R, Villa M, Lucchi S, Valkhoff V, Romio S, Thiessard F, Schuemie M, Pariente A, Sturkenboom M, Corrao G; on behalf of the Safety of Non‐steroidal Anti‐inflammatory Drugs (SOS) project consortium. Non‐steroidal anti‐inflammatory drugs and risk of heart failure in four European countries: nested case‐control study. BMJ 2016; 354:i4857. Arfè A, Nicotra F, Ghirardi A, Simonetti M, Lapi F, Sturkenboom M, Corrao G; on behalf of the SAFEGUARD project investigators. A probabilistic bias analysis for misclassified categorical exposures, with application to oral anti‐hyperglycaemic drugs. Pharmacoepidemiol Drug Saf 2016 [In press]. Arfè A, Blasi F, Merlino L, Corrao G. Respiratory drugs and macrolides prevent asthma exacerbations: A real‐
world investigation. Respir Med 2016; 119:7‐12. Corrao G, Arfè A, Nicotra F, Ghirardi A, Vaghi A, De Marco R, Pesci A, Merlino L, Zambon A; CRD Real‐World Evidence Scientific Board. Persistence with inhaled corticosteroids reduces the risk of exacerbation among adults with asthma: A real‐world investigation. Respirology 2016; 21:1034‐40. Arfè A, Corrao G. The lag‐time approach improved drug‐outcome association estimates in presence of protopathic bias. J Clin Epidemiol 2016 [In press]. Arfè A, Nicotra F, Cerveri I, de Marco R, Vaghi A, Merlino L, Corrao G. Incidence, Predictors, and Clinical Implications of Discontinuing Therapy with Inhaled Long‐Acting Bronchodilators among Patients with Chronic Obstructive Pulmonary Disease. COPD 2016: 13:540‐6. Arfè A, Corrao G. Tutorial: strategies addressing detection bias were reviewed and implemented for investigating the statins‐diabetes association. J Clin Epidemiol 2015; 68(5):480‐8. Carrara G, Sciré CA, Zambon A, Cimmino MA, Cerra C, Caprioli M, Cagnotto G, Nicotra F, Arfè A, Migliazza S, Corrao G, Minisola G, Montecucco C. A validation study of a new classication algorithm to identify rheumatoid arthritis using administrative health databases: case‐control and cohort diagnostic accuracy studies ‐ Results from the RECord linkage On Rheumatic Diseases study of the Italian Society for Rheumatology. BMJ Open 2015;5:e006029 Corrao G, Soranna D, Arfè A, Casula M, Tragni E, Merlino L, Mancia G, Catapano AL. Are generic and brand‐
name statins clinically equivalent? Evidence from a real data‐base. Eur J Intern Med 2014; 25:745‐50. Scotti L, Arfè A, Zambon A, Merlino L, Corrao G. Cost‐effectiveness of enhancing adherence with oral bisphosphonates treatment in osteoporotic women: an empirical approach based on healthcare utilisation databases. BMJ Open 2014; 4:e003758 Zambon A, Arfè A, Corrao G, Zanchetti A. Relationships of different types of event to cardiovascular death in trials of antihypertensive treatment: an aid to definition of total cardiovascular disease risk in hypertension. J Hypertens 2014; 32:495‐508. Valkhoff VE, Schade R, 't Jong GW, Romio S, Schuemie MJ, Arfè A, Garbe E, Herings R, Lucchi S, Picelli G, Schink T, Straatman H, Villa M, Kuipers EJ, Sturkenboom MC; on behalf of the Safety of Non‐steroidal Anti‐
inflammatory Drugs (SOS) project investigators. Population‐based analysis of non‐steroidal anti‐inflammatory drug use among children in four European countries in the SOS project: what size of data platforms and which study designs do we need to assess safety issues? BMC Pediatr 2013; 13:192. Malvezzi M, Arfè A, Bertuccio P, Levi F, La Vecchia C, Negri E. European cancer mortality predictions for the year 2011. Ann Oncol 2011; 22:947‐56. Arfè A, Malvezzi M, Bertuccio P, Decarli A, La Vecchia C, Negri E. Cancer mortality trend analysis in Italy, 1970‐
2007. Eur J Cancer Prev 2011; 20:364‐74. Refereeing Ad‐hoc referee/reviewer for: Journal of Clinical Epidemiology; Drug Safety; Pharmacoepidemiology and Drug Safety; Pediatrics; Tumori Journal. Professional Experience 2010‐2015 Research assistant (full time), Unit of Pharmacoepidemiology and Healthcare Research, Department of Statistics and Quantitative methods, University of Milano‐Bicocca, Milan, Italy ‐Statistical analysis of large healthcare databases ‐Participated in two EU‐funded international projects (SOS Project, SAFEGUARD Project) 2015 Contract statistician (part time), Institute of Ecosystem Studies (ISE), Italian National Research Council (CNR), Verbania Pallanza, Italy. ‐Functional Principal Components analysis of limnological data Nov. 2010‐Feb. 2011 Internship (part time), Department of Epidemiology, “Mario Negri” Research Institute, Milan, Italy ‐Trend analysis and short‐term forecasting of cancer mortality rates Teaching experience 2016: Teaching Assistant, Bachelor's level course in Statistics, Bocconi University, Milan, Italy. 2015: Teaching Assistant, Masters‐level course in "Pharmacoepidemiology", University of Milano‐Bicocca, Milan, Italy. 2014: Faculty member, V edition of the course “A short course on concepts and methods in Causal Inference", Milan, Italy, of the Italian Society of Medical Statistics and Clinical Epidemiology. 2012: Teaching Assistant, Master’s level e‐learning course “Methodology of Clinical and Observational Research”, University of Milano‐Bicocca, Milan, Italy. Language Skills Italian: mother tongue English: Cambridge FCE certificate (CEFR level: B2) IT Skills - Word, Excel, Power Point, LaTeX (good) - SAS, R, Stan, BUGS (good) - Python, C, Matlab, SQL (basic)